<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02883192</url>
  </required_header>
  <id_info>
    <org_study_id>BnaiZionMC-16-LG-011</org_study_id>
    <nct_id>NCT02883192</nct_id>
  </id_info>
  <brief_title>The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia</brief_title>
  <official_title>The Effect of Preventive Use of Ondansetron on the Blood Pressure and Vasopressor Consumption in the Cesarean Section Under Spinal Anesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bnai Zion Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bnai Zion Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cesarean section is a frequent procedure in the obstetric surgery. The most widely used&#xD;
      anesthesia technique for cesarean delivery is the spinal anesthesia The incidence of spinal&#xD;
      anesthesia induced hypotension and bradycardia is high as 60% in the obstetric population.&#xD;
      The aim of the study is to investigate the effect of the preventive use of Ondansetron on the&#xD;
      prevention of hypotension&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean section is a frequent procedure in the obstetric surgery. The most widely used&#xD;
      anesthesia technique for cesarean delivery is the spinal anesthesia, in our Institute over&#xD;
      than 90% of the elective cesarean sections are under spinal anesthesia, however this kind of&#xD;
      anesthesia frequently associated with, side effects that affect primarily the parturient and&#xD;
      the fetal health. The incidence of spinal anesthesia induced hypotension and bradycardia is&#xD;
      high as 60% in the obstetric population . Most authors agree that hypotension presents when&#xD;
      the systolic blood pressure decrease under 90 mmHg, or when there is a reduction from&#xD;
      baseline of more than 20-30 %. Augmentation of the intravascular volume with crystalloids and&#xD;
      vasopressors is the cornerstone of the treatment of spinal anesthesia induced hypotension,&#xD;
      the vasopressors usually used are the α and β receptors agonist ephedrine and the selective α&#xD;
      agonist phenylephrine that, gain popularity in the last years, because it's more efficacy in&#xD;
      maintaining the umbilical cord blood PH and the Apgar score of the neonates. However many&#xD;
      studies showed that it was inefficient and no intervention reliably prevents hypotension&#xD;
      after spinal anesthesia for cesarean section and, bradycardia can occur from shift in cardiac&#xD;
      autonomic balance toward the parasympathetic system from activation of left ventricular&#xD;
      mechanoreceptors after sudden decrease in left ventricle volume causing the Bezold Jarish&#xD;
      Reflex (BJR). Animal studies suggest that 5-HT( serotonin) may play an important factor&#xD;
      associated inducing the BJR and this effect can be blocked at the 5-HT3 receptor using the&#xD;
      serotonin inhibitor Ondansetron, commonly used antiemetic . Despite the fact that Ondansetron&#xD;
      was evaluated in the management of spinal anesthesia induced hypotension in large&#xD;
      heterogeneity and small samples , the need for more investigation in big number of cesarean&#xD;
      sections still needed.&#xD;
&#xD;
      The aim of the study is to investigate the effect of the preventive use of Ondansetron on the&#xD;
      prevention of hypotension and the amount of vasopressor phenylephrine needed to control the&#xD;
      hypotension after spinal anesthesia and the possible effect on the umbilical cord blood PH&#xD;
      and the Apgar score in one minute after delivery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood pressure measure in mmHg.</measure>
    <time_frame>40 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Vomiting measure in number scale</measure>
    <time_frame>40 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Adverse Anesthesia Outcome</condition>
  <arm_group>
    <arm_group_label>ondansetron</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ondansetron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron</intervention_name>
    <description>Zofran 4 mg.</description>
    <arm_group_label>ondansetron</arm_group_label>
    <other_name>Zofran</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        American Society of Anesthesia (ASA) physical status I or II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Preeclampsia Cardiovascular disease&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mira koch, M.A.</last_name>
    <role>Study Chair</role>
    <affiliation>Bnai Zion Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Luis A Gaitini, M.D.</last_name>
    <phone># 972 4 8359346</phone>
    <email>luis.gaitini@b-zion.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mostafa Somri, M.D.</last_name>
    <phone># 972 4 8359304</phone>
    <email>mostafa.somri@b-zion.org.il</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Luis A Gaitini M.D.</name>
      <address>
        <city>Haifa</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luis A Gaitini, M.D.</last_name>
      <phone># 972 4 8359346</phone>
      <email>luis.gaitini@b-zion.org.il</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 25, 2016</study_first_submitted>
  <study_first_submitted_qc>August 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 30, 2016</study_first_posted>
  <last_update_submitted>August 30, 2016</last_update_submitted>
  <last_update_submitted_qc>August 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 31, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bnai Zion Medical Center</investigator_affiliation>
    <investigator_full_name>LUIS.GAITINI</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Cesarean section</keyword>
  <keyword>spinal anesthesia</keyword>
  <keyword>hypotension</keyword>
  <keyword>ondansetron</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ondansetron</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

